-
Mashup Score: 1Jason Sheehan: The role of angiogenesis inhibitors on glioblastoma management - OncoDaily - 19 day(s) ago
Jason Sheehan: The role of angiogenesis inhibitors on glioblastoma management / Ali Mohammad Mokhtari, Ali Mortezaei, Ali Motamed-Sanaye, Amir Afshari, Amir
Source: oncodaily.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 35
Journal of Neuro-Oncology – Pseudoprogression is an atypical imaging pattern of response to immunotherapy in patients with brain tumors. MR perfusion studies in this field are limited. The purpose…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Chen et al. compared MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy with pseudoprogression after chemo-radiation and radiation necrosis after radiation. #JNO Read more:https://t.co/sFzeUcPLpG https://t.co/zr1HN9zEWX
-
-
Mashup Score: 1
Journal of Neuro-Oncology – Chordomas are malignant tumors of the axial spine and skull base, and they are notorious for their poor treatment response. Differentiating these tumors from…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Vanderheijden et al. showed that the differential expression of chordin, HOXA5, ACAN, and CD24 could be relevant for the pathophysiology of chordomas and may have diagnostic and treatment value. #JNO Read more:https://t.co/3hZ6uwN1ak https://t.co/5LwjEuoAg3
-
-
Mashup Score: 6Health-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study - 1 month(s) ago
Journal of Neuro-Oncology – Few studies have evaluated the health-related quality of life (HRQoL) of patients with diffuse low-grade glioma (LGG) during a clinical and radiological monitoring…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Obara et al. assessed the quality of life of patients with diffuse low-grade glioma and showed significantly lower cognitive, emotional, role, and social functioning than the normative population. #JNO Read more:https://t.co/bN4MWjxrW6 https://t.co/aM5JijYort
-
-
Mashup Score: 18
Journal of Neuro-Oncology – Chimeric antigen receptor (CAR) T cell therapy is an exciting modality of immunotherapy that has revolutionized the treatment of hematologic malignancies. However,…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Grewal et al @MGHpathology @MGHNeurosurg demonstrated in an excellent review article that the rapid evolution of investigational CAR T cell therapies portends great potential for the future of glioma treatment. #JNO Read more: https://t.co/9uJdDcbMSB https://t.co/hfHaqTQPkJ
-
-
Mashup Score: 8
Journal of Neuro-Oncology – Glioblastoma (GBM) that presents as leptomeningeal disease (LMD) is extremely rare and fatal. Limited data are available regarding incidence, clinical presentation, and…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Mondia et al. @arasthagiri @UVAneurosurg @UVANeurology reported the first case of GBM presenting exclusively as LMD without a primary lesion and provided diagnostic and therapeutic recommendations. #JNO Read more: https://t.co/2LA2c8rEN0 https://t.co/fPE106jQZO
-
-
Mashup Score: 4Journal of Neuro-Oncology Editorial Newsletter - 1 month(s) ago
Welcome to the Journal of Neuro-Oncology newsletter for 2024. In this newsletter, we would like to share with you some journal highlights and current developments for Journal of Neuro-Oncology.
Source: sway.cloud.microsoftCategories: General Medicine News, Oncologists1Tweet-
We are pleased to present our latest newsletter. We have highlighted a few of the many accomplishments the journal has achieved in 2024! #JNO Link: https://t.co/TiYparMzir
-
-
Mashup Score: 8Prognostic value of immunohistochemical staining for H3K27me3 and EZH2 in astrocytoma, IDH-mutant - 1 month(s) ago
Journal of Neuro-Oncology – H3 histone 27 lysine (H3K27) trimethylation (H3K27me3), which is catalyzed by enhancer of zeste homolog 2 (EZH2), regulates gene expression through epigenetic…
Source: link.springer.comCategories: General Medicine News, Onc News and JournalsTweet-
Onishi et al. showed that double positivity for H3K27me3 & EZH2 may signal poor prognosis in astrocytoma, IDH-mutant. These markers could help refine risk stratification and patient management. #JNO Read more: https://t.co/qeuSPaWiby https://t.co/uqV0IQAj2g
-
-
Mashup Score: 10Patterns of failure after stereotactic radiosurgery for brain metastases from small cell lung cancer: outcomes in the immunotherapy era - 1 month(s) ago
Journal of Neuro-Oncology – Small cell lung cancer (SCLC) is known to have high rates of development of brain metastases. Standard treatment has been whole brain radiation therapy (WBRT) but the…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Marwaha et al. @alex_marwaha @ahnneuroscience showed a similar distant brain failure rate after SRS for brain metastases from small cell lung cancer to those of NSCLC in the immunotherapy era. #JNO Read more: https://t.co/f2XoptAQnZ https://t.co/5mKndOBGA5
-
-
Mashup Score: 7
Journal of Neuro-Oncology – Prophylactic insertion of an external ventricular drainage (EVD) prior to the resection of posterior fossa metastases (PFMs) is a common approach to address…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Shabo et al @UniklinikBonn reported pre-operative risk factors for the occurrence of post-operative hydrocephalus following surgery of brain metastases in the posterior fossa. #JNO Read more: https://t.co/cfVo4evfXG https://t.co/50jk5CSJJb
-
RT @oncodaily: The role of angiogenesis inhibitors on glioblastoma management - @jasonpsheehan @JNeurooncol https://t.co/6B2Mw2MvxM #Can…